Breaking News
March 24, 2019 - Practices for Reducing COPD Hospital Readmissions Explored
March 24, 2019 - Could an eye doctor diagnose Alzheimer’s before you have symptoms?
March 24, 2019 - Enzyme inhibitor stops inflammation and neurodevelopmental disorders in mouse models
March 24, 2019 - Walk, Dance, Clean: Even a Little Activity Helps You Live Longer
March 24, 2019 - Americans used less eye care in 2014 versus 2008
March 24, 2019 - Study finds link between depression in 20s linked to memory loss in 50s
March 24, 2019 - New tool helps physiotherapy students to master complex fine motor skills
March 24, 2019 - The AMR Centre secures £2.3m funding boost
March 24, 2019 - Study examines effects of taking ondansetron during first trimester of pregnancy
March 24, 2019 - Researchers identify a more effective treatment for cancer
March 24, 2019 - Open-source solution for multiparametric optical mapping of the heart’s electrical activity
March 24, 2019 - New nanotechnology approach shows promise in treating triple negative breast cancer
March 24, 2019 - Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain
March 24, 2019 - Maternal deaths following C-section 50 times higher in Africa compared to high-income countries
March 24, 2019 - Apple watch could detect irregular heart beat says study
March 24, 2019 - Queen Mary University of London’s BCI boosts radionuclide imaging capabilities with MILabs VECTor technology
March 24, 2019 - Girls should be encouraged to gain more ball skills, shows study
March 24, 2019 - Acute doses of synthetic cannabinoid can impair critical thinking and memory
March 24, 2019 - Presence of bacteria in urine does not always point to infection, shows study
March 24, 2019 - Scientists identify a new role for nerve-supporting cells
March 24, 2019 - Hidden differences between pathology of CTE and Alzheimer’s disease discovered
March 24, 2019 - Knowing causative genes of osteoporosis may open door to more effective treatments
March 24, 2019 - Toilet-seat based cardiovascular monitoring system getting ready to begin commercialization
March 24, 2019 - New model for intensive care identifies factors that send ill patients to ICU
March 24, 2019 - Recommendations Issued for HSCT in Multiple Myeloma
March 24, 2019 - Deep brain stimulation provides sustained relief for severe depression
March 24, 2019 - “Statistical significance” may soon be a thing of past?
March 24, 2019 - Researchers track effects of epigenetic marks carried by sperm chromosomes
March 24, 2019 - AHA News: Family Adopts Three Children With Three Different Heart Conditions
March 24, 2019 - Research into opioid painkillers could provide clues for safer drug development
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
D.C. Week: Congress Passes Spending Bill

D.C. Week: Congress Passes Spending Bill

image_pdfDownload PDFimage_print

WASHINGTON — Just before dawn on Friday, Congress passed another short-term spending bill that addresses several significant healthcare issues, such as the opioid crisis and keeping community health centers running, and it keeps the government open until late March.

Congress Passes Short-Term Spending Bill

Congress passed a stopgap spending bill early Friday that included 10 years of funding for the Children’s Health Insurance Program (CHIP) and $7.8 billion for community health centers (CHCs), and permanently removed a cap on Medicare outpatient therapy payments.

The measure passed by a vote of 71-28 in the Senate and 240-186 in the House; President Trump has signed it.

The bill, which will keep the government open through March 23, also includes funding for assisting victims of national disaster in Puerto Rico and the U.S. Virgin Islands, and it repeals the Independent Payment Advisory Board (IPAB), an unpopular feature of the Affordable Care Act. It also extends CHIP for 10 years, up from the 6-year extension the program received in the previous short-term spending bill.

The CHIP extension is “just remarkable providing unprecedented security and certainty for the families that depend on CHIP, and the state governments that need more predictability to map out their own expenditures,” said Sen. Orrin Hatch (R-Utah).

Top Democrat Blasts GOP on Healthcare

Saying congressional Republicans have made “concerted efforts” to be “deeply disruptive” towards American healthcare, House Minority Whip Steny Hoyer (D-Md.) ripped GOP leadership during a speech here Tuesday.

Lawmakers from both parties need to “reach across the aisle” to address healthcare, he declared.

Hoyer, the second-ranking Democrat in the House since 2011 and House Majority Leader from 2007-2011, spoke at the AcademyHealth National Health Policy Conference for 20 minutes in a hastily-scheduled session that organizers had squeezed into the program only the day before. He rarely looked down at his notes as he addressed a packed hotel ballroom, seeming less like a politician and more like a man who had something to get off his chest.

“What America’s healthcare system needs is stability,” Hoyer said, hammering on staple Democratic themes regarding Republican efforts to undermine the Affordable Care Act and the “dangerous instability” that has resulted.

More Help Needed With Opioid Crisis, Senators Told

Congress has made strides in helping battle the opioid abuse epidemic, but much more needs to be done, witnesses told a Senate committee on Thursday.

“The opioid epidemic is taking a terrible toll on pregnant women and infants,” Stephen Patrick MD, MPH, a neonatologist at Vanderbilt University, in Nashville, Tenn., said at a Senate Health, Education, Labor, & Pensions (HELP) Committee hearing on the effect of the opioid crisis on children and families. “Every day, people are dying. Pregnant women are not getting the treatment they need and infants are spending their first few weeks in withdrawal … These are our brothers and sisters and they need our help.”

Legislation passed by Congress, including the Comprehensive Addiction and Recovery Act, the 21st Century Cures Act, and the Protecting Our Infants Act “moved forward important public health priorities but would benefit from additional [reinforcement],” Patrick said. For example, “The Protecting our Infants Act resulted in a comprehensive strategy document from SAMHSA [the Substance Abuse and Mental Health Services Administration], but as [SAMHSA] notes, implementation is dependent on funding.”

Pressure Rises for Right-to-Try Bill

Earlier this week, two Republican congressmen sent a letter to House Speaker Paul Ryan (R-Wis.) and Majority Leader Kevin McCarthy (R-Calif.) urging them to bring a “right-to-try” bill to a vote in the House as soon as possible.

The bill, called the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act, passed in the Senate last August.

It would allow individuals with life-threatening illnesses to obtain experimental drugs prior to FDA approval. However, the law does not require drug companies to make their products available, and the FDA already has a pathway to allow such access. Industry in general has not sought changes to that pathway. Nevertheless, some in Congress are unsatisfied with the FDA’s policies and implementation and are seeking to loosen the reins.

“The fundamental purpose of the Right to Try Act is very simple: it merely allows terminally ill patients who have exhausted all other options to try medications that have passed basic Food and Drug Administration safety protocols but not completed the full, multi-year approval process. This bill safeguards any pharmaceutical company that may wish to participate in Right to Try, but it in no way requires participation to begin with,” wrote Reps. Andy Biggs (R-Ariz.) and Brian Fitzpatrick (R-Pa.) in a letter signed by 40 other members and sent to House leadership on Monday.

New 3-Drug Combo for HIV OK’d

A new three-drug combination pill for HIV-1 infection won FDA approval late Wednesday, said manufacturer Gilead Sciences.

To be sold as Biktarvy, the product includes the integrase inhibitor bictegravir and two reverse transcriptase inhibitors, emtricitabine and tenofovir alafenamide. It is approved for once-daily oral administration, with no food intake requirement, baseline viral load, or CD4+ cell count restrictions, Gilead said.

The drug combination was tested in numerous clinical trials. Last July, for example, investigators reported on two phase III studies in which the product was given as first-line therapy, achieving undetectable viral loads in 90% of patients. Those studies also suggested that resistance to the combination would be slow to develop.

Next Week

On Monday, President Trump is expected to release his FY 2019 budget proposal.

On Wednesday and Thursday, the FDA’s Anesthetic and Analgesic Drug Products Advisory Committee will meet to discuss Exparel (bupivacaine liposomal injectable suspension) for “local analgesia and as a nerve block to produce regional analgesia.”

And on Wednesday only, the same committee and the FDA’s Drug Safety and Risk Management Advisory Committee will assess Hydexor, a fixed-dose combination oral tablet, “that contains hydrocodone, acetaminophen, and promethazine,” for treating severe, short-term acute pain.

Also on Wednesday, a subcommittee on Oversight and investigations for the House Committee on Energy and Commerce will evaluate the impact of healthcare consolidation

On Thursday, a health subcommittee for House Committee on Energy & Commerce will explore the oversight of the Department of Health and Human Services.

2018-02-10T12:00:00-0500

Tagged with:

About author

Related Articles